The principle behind differentiation therapy is based on the understanding that cancer cells often resemble immature, undifferentiated cells. By using certain agents, it is possible to trigger these cells to differentiate and lose their malignant properties. Agents used in differentiation therapy can include retinoids, histone deacetylase inhibitors (HDAC inhibitors), and other small molecules that modulate gene expression and cellular pathways.
